Etiometry and SHRO to enhance patient outcomes and save costs with AI-based decision support

Partnerships
Orion Health and Pieces join forces to unlock the potential of trusted AI in healthcare
Together, Orion Health’s Orchestral Health Intelligence Platform (HIP) and Pieces’ premier AI technology, commonly known as ‘Pieces,’ will revolutionize healthcare by giving clinicians and carers access to a trusted AI solution that is calibrated on extensive, locally produced data. Read More>>
Gloucester Rugby continues its partnership with Nuffield Health
Gloucester Rugby and Nuffield Health have partnered to give players access to world-class medical centers, assuring their performance and fitness. Additionally supporting the health of the group and nearby communities is Nuffield Health. Read More>>

Centre Setup and Expansion
Apollo Hospitals expands healthcare reach in Gurugram with outreach services
Expanding healthcare access is a goal of Apollo Hospitals’ new facility in Gurugram, Haryana, and the Delhi NCR, which is in line with their dedication to offering top-notch services and encouraging medical travel. The facility will develop into a premier multi-specialty hospital that will serve the region’s various medical needs. Read More>>

Executive Movement
Digital Health Agency appoints new Chair
The Australian Digital Health Agency’s new Chair will be Lyn McGrath. Following the agencies’ work on the My Health Record and the My Health app, as well as electronic prescriptions and a period of rapid innovation during the Covid-19 pandemic, Ms. McGrath will spearhead the evolution of digital health. Read More>>

Layoff
ProMedica lays off 20 administrative workers
Due to shifting objectives and financial difficulties, Toledo’s ProMedica is letting off about 20 administrative staff members. This follows an earlier wave of layoffs that involved 262 employees and an operating loss of US$ 39.8 Mn in August. For stability, the health system is placing a stronger emphasis on clinical functions and cancelling some projects. Read More>>

Partnerships
Etiometry partners with SRHO for AI-based hospital decision support in the U.S.
Through a collaboration with SRHO, Etiometry improves the effectiveness and results of the ICU. The improvement of critical care and cost reduction are the goals of this collaboration for the participating hospitals. With the use of Etiometry’s technology, high-acuity hospital units are to be optimized. Read More>>
DHL partners with Alcon
In Australia, DHL Supply Chain collaborates with Alcon to offer a focused 3PL solution, storing and shipping surgical and vision care products for the local market. The requirement for medical device quality compliance and DHL’s adaptable network capabilities are the driving forces behind the relationship. Read More>>

Merger and Acquisition
Enovis to acquire LimaCorporate for more than US$ 840 Mn
The acquisition results in a US$ 1 Bn reconstruction project. Enovis estimates US$ 40 Mn in cost savings and long-term organic revenue growth in the high single digits. It also anticipates increased efficiency with cutting-edge production facilities and a robust innovation engine. Read More>>

Executive Movement
Nanaz Mohtashami elected to the Hologic Board of Directors
Nanaz Mohtashami has been appointed to Hologic’s Board of Directors. Nominating and Corporate Governance Committee.  A Managing Director at Russell Reynolds Associates brings extensive experience in global strategy and healthcare to the role. Read More>>

Product Launch
iRhythm launches wearable ECG heart monitor
The Zio monitor from iRhythm Technologies is a smaller, lighter, and more comfortable cardiac monitoring device that improves diagnostic accuracy and patient experience. These goals are to increase diagnostic accuracy and patient experience in cardiac monitoring to achieve better outcomes. Read More>>

Partnership
Sanofi signs two-year partnership with Delta State to improve diabetes care
Sanofi and Delta State University have agreed to a two-year collaboration to expand access to affordable diabetes care and provide digital solutions that would benefit both healthcare professionals and patients. The goal is to treat diabetes-related issues in underprivileged populations. Read More>>

Centre Setup and Expansion
Aurobindo Pharma Foundation opens community hall in Andhra Pradesh’s Chinthapalli Village
The Aurobindo Pharma Foundation dedicates a multi-purpose community hall in Chinthapalli Village, Andhra Pradesh, to promote community development and empowerment. The hall, which would cost INR 80 lakhs (US$ 96K) and span 4,448 square feet, will benefit around 9,000 villages and will act as a platform for community gatherings and initiatives. Read More>>

Merger and Acquisition
Biogen acquires Reata Pharmaceuticals
Biogen’s acquisition of Reata Pharmaceuticals, adds SKYCLARYS for Friedreich’s ataxia to their rare disease portfolio. The purchase is consistent with Biogen’s aim to improve patient care while driving long-term growth. Read More>>

Executive Movement
Galapagos appoints Simon Sturge to its Board of Directors
Galapagos has appointed Simon Sturge, to its Board of Directors as a Non-Executive Independent Director. Sturge brings over 40 years of international experience, including leadership roles at Merck KGaA and Boehringer Ingelheim, and CEO positions at various biotech companies. Read More>>

• Regeneron is actively advancing innovative combinations of cell therapy for solid tumors by integrating T-cell therapy research, antibody development, and bispecific approaches. Their primary aim is to create effective therapies for solid tumors, emphasizing the importance of employing various strategies within cell-based immunotherapy. 
• It utilizes a comprehensive scientific and manufacturing cell therapy platform to conduct clinical trials involving advanced CAR-T variations in partnership with cutting-edge biologics. This strategic method is well-suited to accelerate the identification and development of profoundly impactful treatments.

Bispecific Antibodies for Cancer Therapy

• Regeneron focuses on developing innovative cancer therapies combining Probody and Veloci-Bi platforms to create investigational bispecific cancer therapies. These therapies stay inactive until triggered by enzymes in the tumor, potentially reducing side effects. 
• This technology widens the therapeutic window and helps minimize off-target effects for these next-generation T-cell-engaging therapies, potentially addressing tumor types that have historically been unresponsive to immunotherapy. 
• Regeneron is developing a paradigm-changing portfolio of oncology medicines for patients by combining a deep understanding of cancer biology with cutting-edge technologies.

 

Key Funding Alert

Triastek raises US$ 20.4 Mn to 3D print pharmaceuticals
The financing will help the company develop novel pharmaceutical products and expand cooperation with major pharmaceutical corporations. Triastek has obtained many patents and regulatory permissions for its 3D-printed items. Read More>>

Startup Spotlight

Company – Alma Health
Total Funding – USD 10 Mn
About: Alma Health is a digitally native chronic illness management software that transforms patient behavior and insights into personalized services and goods such as digital therapies and at-home monitoring systems through its cloud pharmacy and virtual doctor consultations. Read More>>

Here’s what’s new on our Sales Intelligence Platform
Use JD Reader Co-Pilot to leverage AI and have your talent demand queries answered

• Harness the capabilities of AI to swiftly resolve your talent demand queries through the cutting-edge JD Reader Co-Pilot feature.
• Introducing the ‘My Accounts’ filter in JD reader to enable you to find job postings from companies saved in the ‘My Accounts’ list.